Recombinetics
Recombinetics is a St. Paul, Minnesota-based bio-engineering company.[1] The company was founded in 2008, and has since raised $31 million from private investors. Mark Platt is the CEO.[2]
In November 2024, Recombinetics filed for Chapter 11 bankruptcy protection. The company has plans to be acquired by Trans Ova Genetics for $4.1 million.[3]
Products
[edit]It is known for developing genetically engineered hornless cattle, and is working on growing human organs and tissues in pigs.[4] While it created a cow that does not grow horns, during the creation process it also added genes from bacteria that could produce antibiotic resistance.[5] This occurred despite the CEO claiming that they had proof there were no other effects than the horns not being present.[5] Due to the bacterial DNA, it is unlikely that the animals will get FDA approval, and a number of them have been killed and the bodies burned.[5]
References
[edit]- ^ Schaust, Sam (1 May 2017). "Recombinetics Raises $7M, Hints at Bigger Funding Efforts Ahead". Twin Cities Business. Archived from the original on 2017-05-01. Retrieved 27 September 2017.
- ^ "Recombinetics Announces New Chief Executive Officer". www.businesswire.com. 2019-02-11. Retrieved 2020-08-12.
- ^ >Stefanescu, Victor (November 13, 2024). "Recombinetics, which engineered hornless dairy bulls, files for bankruptcy". Star Tribune. Retrieved November 13, 2024.
- ^ Pettitt, Jeniece (9 September 2017). "These pigs are helping researchers find cures for cancer, and could someday grow human organs". CNBC. Retrieved 27 September 2017.
- ^ a b c Regalado, Antonio. "Gene-edited cattle have a major screwup in their DNA". MIT Technology Review. Retrieved 31 August 2019.
 | This United States corporation or company article is a stub. You can help Wikipedia by expanding it. |